Mitsubishi UFJ Trust & Banking Corp Sells 1,623 Shares of Chemed Co. (NYSE:CHE)

Mitsubishi UFJ Trust & Banking Corp lessened its stake in Chemed Co. (NYSE:CHE) by 92.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 136 shares of the company’s stock after selling 1,623 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp’s holdings in Chemed were worth $72,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in CHE. Raymond James Financial Inc. bought a new stake in shares of Chemed in the 4th quarter valued at about $42,023,000. FMR LLC increased its stake in Chemed by 23.8% in the third quarter. FMR LLC now owns 238,616 shares of the company’s stock valued at $143,401,000 after purchasing an additional 45,917 shares in the last quarter. Principal Financial Group Inc. raised its holdings in Chemed by 114.1% in the fourth quarter. Principal Financial Group Inc. now owns 74,658 shares of the company’s stock worth $39,554,000 after purchasing an additional 39,791 shares during the period. Segall Bryant & Hamill LLC bought a new position in shares of Chemed during the fourth quarter worth $12,880,000. Finally, Boston Trust Walden Corp grew its holdings in shares of Chemed by 10.0% in the 4th quarter. Boston Trust Walden Corp now owns 242,172 shares of the company’s stock valued at $128,303,000 after buying an additional 22,105 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Stock Down 0.7 %

Shares of NYSE:CHE opened at $614.41 on Thursday. The firm has a market cap of $8.99 billion, a price-to-earnings ratio of 31.05, a PEG ratio of 2.15 and a beta of 0.43. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $639.61. The company’s fifty day simple moving average is $577.76 and its 200 day simple moving average is $567.62.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a $0.50 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. Chemed’s dividend payout ratio (DPR) is 10.05%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on CHE shares. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Royal Bank of Canada boosted their price objective on Chemed from $633.00 to $667.00 and gave the company an “outperform” rating in a research report on Friday, March 14th.

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the sale, the chief executive officer now owns 101,679 shares in the company, valued at approximately $62,566,139.07. The trade was a 0.97 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 3.32% of the stock is owned by insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.